Enzo Biochem
ENZ
$1.38
Share price
0.73%
Change (1 day)
-45.02%
Change (1 year)
Categories
P/S ratio for Enzo Biochem (ENZ)
P/S ratio as of September 2023 (TTM): 0.9786
According to Enzo Biochem's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.978635. At the end of 2023 the company had a P/S ratio of 1.77.
P/S ratio history for Enzo Biochem from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.77 | 67.73% |
| 2022 | 1.05 | -26.86% |
| 2021 | 1.44 | 39.78% |
| 2020 | 1.03 | -44.98% |
| 2019 | 1.88 | 17.68% |
| 2018 | 1.59 | -62.33% |
| 2017 | 4.23 | 55.72% |
| 2016 | 2.72 | 55.35% |
| 2015 | 1.75 | -27.63% |
| 2014 | 2.42 | 116.86% |
| 2013 | 1.11 | 46.1% |
| 2012 | 0.7630 | -29.41% |
| 2011 | 1.08 | -35.88% |
| 2010 | 1.69 | -24.3% |
| 2009 | 2.23 | -18.02% |
| 2008 | 2.72 | -62.74% |
| 2007 | 7.29 | -36.68% |
| 2006 | 11.5 | 13.43% |
| 2005 | 10.1 | -26.26% |
| 2004 | 13.8 | 11.74% |
| 2003 | 12.3 | 74.3% |
| 2002 | 7.07 | -24.46% |
| 2001 | 9.35 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 1.47 | 50.25% | 🇺🇸 USA |
 LabCorp LH | 1.31 | 33.90% | 🇺🇸 USA |
 RadNet RDNT | 1.25 | 27.93% | 🇺🇸 USA |
 Psychemedics PMD | 0.8949 | -8.56% | 🇺🇸 USA |
 NeoGenomics
NEO | 2.86 | 192.04% | 🇺🇸 USA |
 Qiagen QGEN | 4.51 | 361.29% | 🇳🇱 Netherlands |